Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase 2 study of single-agent IV vinflunine as third-line treatment of metastatic breast cancer after failure of anthracycline-/taxane-based chemotherapy.
Fumoleau P, Cortés-Funes H, Taleb AB, Chan S, Campone M, Pouget JC, Tubiana-Hulin M, Slabber CF, Caroff-Paraïso I, Alberts AS, Ben Ayed F. Fumoleau P, et al. Among authors: slabber cf. Am J Clin Oncol. 2009 Aug;32(4):375-80. doi: 10.1097/COC.0b013e31818f2d2f. Am J Clin Oncol. 2009. PMID: 19487917 Clinical Trial.
Vinflunine: a new active drug for second-line treatment of advanced breast cancer. Results of a phase II and pharmacokinetic study in patients progressing after first-line anthracycline/taxane-based chemotherapy.
Campone M, Cortes-Funes H, Vorobiof D, Martin M, Slabber CF, Ciruelos E, Bourbouloux E, Mendiola C, Delgado FM, Colin C, Aslanis V, Fumoleau P. Campone M, et al. Among authors: slabber cf. Br J Cancer. 2006 Nov 6;95(9):1161-6. doi: 10.1038/sj.bjc.6603347. Epub 2006 Oct 10. Br J Cancer. 2006. PMID: 17031408 Free PMC article. Clinical Trial.
The ubiquitin ligase Uhrf2 is a master regulator of cholesterol biosynthesis and is essential for liver regeneration.
Slabber CF, Bachofner M, Speicher T, Kuklin A, Fearon AE, Padrissa-Altés S, Bogorad R, Horváth Rudigier C, Wüst D, Krautbauer S, Höring M, Liebisch G, Anderson DG, Wolfrum C, Auf dem Keller U, Werner S. Slabber CF, et al. Sci Signal. 2023 May 30;16(787):eade8029. doi: 10.1126/scisignal.ade8029. Epub 2023 May 30. Sci Signal. 2023. PMID: 37253089
The treatment of multiple myeloma using vincristine, carmustine, melphalan, cyclophosphamide, and prednisone (VBMCP) alternating with high-dose cyclophosphamide and alpha(2)beta interferon versus VBMCP: results of a phase III Eastern Cooperative Oncology Group Study E5A93.
Kyle RA, Jacobus S, Friedenberg WR, Slabber CF, Rajkumar SV, Greipp PR. Kyle RA, et al. Among authors: slabber cf. Cancer. 2009 May 15;115(10):2155-64. doi: 10.1002/cncr.24221. Cancer. 2009. PMID: 19248045 Free PMC article. Clinical Trial.
60 results